Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.

MLA

Elalfy, Hatem, et al. “Effect of a Combination of Nitazoxanide, Ribavirin, and Ivermectin plus Zinc Supplement (MANS.NRIZ Study) on the Clearance of Mild COVID-19.” Journal of Medical Virology, vol. 93, no. 5, May 2021, pp. 3176–83. EBSCOhost, https://doi.org/10.1002/jmv.26880.

APA

Elalfy, H., Besheer, T., El-Mesery, A., El-Gilany, A.-H., Soliman, M. A.-A., Alhawarey, A., Alegezy, M., Elhadidy, T., Hewidy, A. A., Zaghloul, H., Neamatallah, M. A. M., Raafat, D., El-Emshaty, W. M., Abo El Kheir, N. Y., & El-Bendary, M. (2021). Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19. Journal of Medical Virology, 93(5), 3176–3183. https://doi.org/10.1002/jmv.26880

Chicago

Elalfy, Hatem, Tarek Besheer, Ahmed El-Mesery, Abdel-Hady El-Gilany, Mahmoud Abdel-Aziz Soliman, Ahmed Alhawarey, Mohamed Alegezy, et al. 2021. “Effect of a Combination of Nitazoxanide, Ribavirin, and Ivermectin plus Zinc Supplement (MANS.NRIZ Study) on the Clearance of Mild COVID-19.” Journal of Medical Virology 93 (5): 3176–83. doi:10.1002/jmv.26880.